蜂助手股份有限公司 前次募集资金使用情况报告 根据中国证券监督管理委员会（以下简称"中国证监会"）《监管规则适用 指引——发行类第 7 号》的规定，将蜂助手股份有限公司（以下简称"公司"或 "蜂助手"）截至 2025 年 6 月 30 日的前次募集资金使用情况报告如下： 一、前次募集资金的募集及存放情况 经中国证券监督管理委员会证监许可[2023]555 号文《关于同意蜂助手股份 有限公司首次公开发行股票注册的批复》的核准，蜂助手股份有限公司（以下简 称"公司"）获准同意首次公开发行股票的注册申请。公司于 2023 年 5 月 5 日 向社会公众投资者定价发行人民币普通股(A 股)4,240 万股，每股面值人民币 1.00 元，每股发行认购价格为人民币23.80元，募集资金总额为人民币1,009,120,000.00 元，扣除与发行有关的费用（不含相关增值税）人民币 113,122,170.92 元，实际 募集资金净额为人民币 895,997,829.08 元。 募集资金总额扣除承销保荐费人民币 79,747,840.00 元（包括相关增值税）， 公司实际收到募集资金人民币 929,372,160.00 元。 ...

蜂助手股份有限公司 2025年度向特定对象发行股票方案的论证 分析报告 二〇二五年九月 证券代码：301382 证券简称：蜂助手 （2）5G 网络推动云终端创新应用场景拓展 5G 网络的发展和边缘计算的兴起为云终端技术的规模化应用提供了重要支持。 根据工信部数据，截至 2025 年 6 月底，我国 5G 基站总数达 455 万个，5G 移动电话 用户为 11.18 亿户，用户普及率超过 79%。随着 5G-A 技术商用推进和 RedCap 等技 术的规模化应用，5G 网络建设进入加速阶段。5G 网络的大带宽特性保障了云端高 清内容向终端设备的流畅传输，毫秒级低延迟则确保了交互操作的实时性；边缘计 算使数据能够就近处理，进一步降低延迟并提升响应速度。这些技术优势共同缓解 2 蜂助手股份有限公司 2025年度向特定对象发行股票方案的论证分析分析报告 蜂助手股份有限公司（以下简称"蜂助手"或"公司"）为满足公司业务发展 的资金需求，增强公司核心竞争力和资本实力，提升盈利能力，促进公司长远发展， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司证券发行注册 管理办法》（以下简称"《注册管理办法》"）等有 ...

证券代码：301382 证券简称：蜂助手 公告编号：2025-087 蜂助手股份有限公司 关于向特定对象发行股票摊薄即期回报的风险提示、填补措施及 相关主体承诺的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 蜂助手股份有限公司（以下简称"公司"或"蜂助手"）于 2025 年 9 月 30 日召 开了第四届董事会第十次会议，审议通过《关于向特定对象发行股票摊薄即期回报的 风险提示、填补措施及相关主体承诺的议案》，现将相关事项公告如下： 根据《关于首发及再融资、重大资产重组摊薄即期回报有关事项的指导意见》 （证监会公告[2015]31 号）、《国务院关于进一步促进资本市场健康发展的若干意见》 （国发[2014]17 号）和《国务院办公厅关于进一步加强资本市场中小投资者合法权益 保护工作的意见》（国办发[2013]110 号）等法律、法规、规章及其他规范性文件的 要求，为保障中小投资者利益，公司就本次向特定对象发行股票（以下简称"本次发 行"）对即期回报摊薄的影响进行了分析和风险提示，并提出了具体的填补回报措施， 相关主体也对公司填补回报措施能够得到切实履行 ...

证券代码：301382 证券简称：蜂助手 公告编号：2025-085 蜂助手股份有限公司 关于 2025 年度向特定对象发行股票预案披露 的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或者重大遗漏。 蜂助手股份有限公司（以下简称"公司"）于 2025 年 9 月 30 日召开第四届 董事会第十次会议、第四届监事会第九次会议，审议通过了公司 2025 年度向特 定对象发行股票的相关议案。公司于 2025 年 9 月 30 日在中国证监会指定的创业 板信息披露网站巨潮资讯网（http://www.cninfo.com.cn）上披露了《蜂助手股份 有限公司 2025 年度向特定对象发行股票预案》及相关文件，敬请投资者注意查 阅。 公司本次向特定对象发行股票预案的披露事项不代表审批机关对公司 2025 年度向特定对象发行股票相关事项的实质性判断、确认或批准，本次向特定对象 发行股票相关事项的生效和完成尚需公司股东大会审议通过及深圳证券交易所 审核通过、中国证券监督管理委员会同意注册，存在一定的不确定性。敬请广大 投资者注意投资风险。 特此公告。 2025 年 9 月 ...

Group 1 - The article discusses a conference featuring various industry experts from sectors such as mining, military, media, chemicals, transportation, new energy, agriculture, finance, automotive, and computing [2] - The conference is scheduled for September 29, 19:00, providing a platform for insights and discussions on industry trends and opportunities [3] Group 2 - The article includes contact information for participants to join the conference, highlighting the accessibility for both domestic and international attendees [4]

设置三级指标评价体系 据介绍，山西省民营经济发展局制订了《民营科技领军企业和新锐企业评价办法》（以下简称《办 法》），对山西省民营科技领军企业和新锐企业作出详细界定。 樊伟强介绍，山西省民营科技领军企业是指在山西省范围内具有一定规模实力，在硬科技投入、产 出、引领性创新等方面取得明显优势，核心产品、工艺、技术或装备居于全省同行业领先地位，能够引 领和带动全产业链创新升级和推动高水平科技自立自强的民营龙头企业。作为科技领军企业的后备队， 山西省民营科技新锐企业是指山西省范围内专注于战略性新兴产业领域，在硬科技投入、产出、引领性 创新等方面取得明显优势，核心产品、工艺、技术或装备能够填补省内产业（或产品）空白，具备较大 成长空间和发展潜力的民营高精尖科技企业。 科技日报记者 赵向南 日前，山西省民营经济发展局公布2025年度山西省民营科技领军企业和新锐企业名单，118家企业 上榜，其中47家为领军企业，71家为新锐企业。这份名单堪称山西省民营科技企业评价的"指挥棒"，引 导民营企业培育和发展新质生产力。"开展山西省民营科技领军企业和新锐企业评价工作，旨在贯彻落 实党中央关于建立培育壮大科技领军企业机制和山西省政府 ...

Core Viewpoint - Pacific Securities research report highlights that Bee Assistant is a well-known digital virtual goods service provider in China, expanding into the IoT + cloud terminal sector [1] Group 1: Company Performance and Goals - The company has set a target for its 2025 equity incentive plan, aiming for a revenue growth rate of no less than 30.30% and a research and development expenditure growth rate of no less than 18.00% based on 2024 [1] - This indicates the company's confidence in future development and a strong commitment to R&D investment [1] Group 2: Market Position and Growth Potential - The company has accumulated a large number of top-tier client resources over the years, establishing a high barrier to entry with core clients [1] - The development momentum in the IoT + cloud terminal business is strong, suggesting a promising second growth curve [1] - The report maintains a "buy" rating for the company [1]

Core Viewpoint - The recent crackdown on illegal use of Class II collagen injections in the medical beauty industry highlights significant consumer risks, with over 23% of medical beauty institutions violating regulations, and a staggering 68% in beauty salons, leading to severe health consequences for consumers [1][3]. Group 1: Health Risks and Violations - A significant number of medical beauty institutions are found to be using unapproved or counterfeit collagen products, leading to severe health issues such as infections and deformities [3][5]. - A case study of a consumer in Nanchang revealed that she was injected with a lower-quality collagen product than promised, resulting in adverse effects and financial loss [4][5]. Group 2: Comparison of Collagen Types - Class II collagen injections are subject to less stringent regulations, requiring only provincial-level registration, while Class III collagen requires extensive clinical trials and safety data, with a failure rate exceeding 70% [10]. - The production environment for Class II collagen is less controlled, increasing the risk of contamination compared to the sterile conditions mandated for Class III products [11]. - The safety profile of Class II collagen is significantly poorer, with adverse event rates exceeding 32%, while Class III products report serious adverse reactions below 0.8% [13]. Group 3: Regulatory Actions and Consumer Protection - The National Medical Products Administration (NMPA) has initiated a "100-day action" to combat illegal practices in the medical beauty sector, emphasizing the need for compliance and consumer safety [1][23]. - Consumers are advised to verify the authenticity of collagen products through official channels and to be wary of suspiciously low prices, which may indicate the use of Class II products [18][22]. - Legal consequences for using Class II collagen can be severe, with operators facing criminal charges for causing harm, as demonstrated by a recent case where a practitioner was sentenced to 7 years in prison for causing a client's blindness [23].

Group 1 - The core business of the company involves providing comprehensive operational services for digital virtual goods aggregation, integration, and distribution in mobile internet scenarios, as well as IoT traffic access and hardware solutions [2] - As of June 30, 2025, the company achieved operating revenue of 983 million yuan, representing a year-on-year growth of 33.83%, and a net profit attributable to shareholders of 76.11 million yuan, with a growth of 5.69% [2] - The company has a total of 34,900 shareholders as of June 30, 2025, which is an increase of 8.88% compared to the previous period [2] Group 2 - On September 23, the company's stock price fell by 4.63%, with a trading volume of 432 million yuan [1] - The financing buy-in amount on September 23 was 47.54 million yuan, while the financing repayment was 43.25 million yuan, resulting in a net financing buy-in of 4.29 million yuan [1] - The total balance of margin trading as of September 23 was 550 million yuan, accounting for 8.75% of the circulating market value, which is above the 80th percentile level over the past year [1]

Group 1 - A total of 41 A-share companies are scheduled for equity registration today [1] - Among these, 41 companies plan to distribute dividends, with Jinbo Biological, Zhejiang Huaye, and Shengyi Technology offering the highest dividends of 10.00 yuan, 4.00 yuan, and 4.00 yuan per 10 shares respectively [1]